Australia markets closed

Imricor Medical Systems, Inc. (IMR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5600-0.0150 (-2.61%)
At close: 04:10PM AEDT

Imricor Medical Systems, Inc.

400 Gateway Boulevard
Burnsville, MN 55337
United States
952 818 8400
https://www.imricor.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Steven WedanPresident, CEO & Executive Chairman684.94kN/A1969
Mr. Jonathon GutCFO & VP of Finance382.14kN/AN/A
Mr. Gregg StenzelChief Operating Officer464.09kN/AN/A
Mr. Greg EnglehardtVice President of Global SalesN/AN/AN/A
Mr. Nick TwohyVice President of Marketing & Business DevelopmentN/AN/AN/A
Mr. Kobe LizhengCompany Secretary & Local AgentN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Corporate governance

Imricor Medical Systems, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.